Chien-Shing Chen

2.8k total citations
60 papers, 2.0k citations indexed

About

Chien-Shing Chen is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Chien-Shing Chen has authored 60 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 20 papers in Hematology and 17 papers in Oncology. Recurrent topics in Chien-Shing Chen's work include Acute Myeloid Leukemia Research (14 papers), Cell death mechanisms and regulation (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). Chien-Shing Chen is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Cell death mechanisms and regulation (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). Chien-Shing Chen collaborates with scholars based in United States, Singapore and China. Chien-Shing Chen's co-authors include Annette M. Marleau, Richard H. Tullis, James A. Joyce, Jianbiao Zhou, Saied Mirshahidi, Philip K. Moore, Yujun Zhao, Lih‐Wen Deng, Choon‐Hong Tan and Ling Li and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Chien-Shing Chen

58 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chien-Shing Chen United States 24 1.1k 434 389 278 276 60 2.0k
Peter Ellinghaus Germany 28 1.6k 1.5× 544 1.3× 444 1.1× 199 0.7× 245 0.9× 74 3.1k
Lita A. Freeman United States 35 1.3k 1.2× 439 1.0× 585 1.5× 193 0.7× 114 0.4× 73 3.2k
Andrew G. Hall United Kingdom 36 2.2k 2.0× 400 0.9× 756 1.9× 226 0.8× 863 3.1× 118 4.0k
David M. Smalley United States 19 807 0.7× 277 0.6× 138 0.4× 104 0.4× 207 0.8× 33 1.8k
Zunyan Dai United States 27 2.2k 2.0× 900 2.1× 665 1.7× 124 0.4× 89 0.3× 45 3.0k
Allan S. Pollock United States 25 805 0.7× 371 0.9× 275 0.7× 53 0.2× 229 0.8× 39 2.0k
Claudia Friesen Germany 24 2.5k 2.2× 507 1.2× 1.1k 2.7× 80 0.3× 222 0.8× 40 3.5k
Lakshmi Puttagunta Canada 23 1.5k 1.3× 812 1.9× 291 0.7× 188 0.7× 79 0.3× 62 3.3k
Françoise Degoul France 26 1.8k 1.6× 214 0.5× 272 0.7× 104 0.4× 63 0.2× 75 2.8k
Ting Zhao China 25 1.5k 1.3× 792 1.8× 482 1.2× 64 0.2× 316 1.1× 105 2.9k

Countries citing papers authored by Chien-Shing Chen

Since Specialization
Citations

This map shows the geographic impact of Chien-Shing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien-Shing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien-Shing Chen more than expected).

Fields of papers citing papers by Chien-Shing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien-Shing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien-Shing Chen. The network helps show where Chien-Shing Chen may publish in the future.

Co-authorship network of co-authors of Chien-Shing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chien-Shing Chen. A scholar is included among the top collaborators of Chien-Shing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien-Shing Chen. Chien-Shing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Huynh, Do Hyun Kim, Ashley Howard, et al.. (2021). Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients’ bone marrow. Neoplasia. 23(12). 1252–1260. 8 indexed citations
2.
Xu, Yi, David J. Baylink, Chien-Shing Chen, et al.. (2020). The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. Journal of Translational Medicine. 18(1). 322–322. 126 indexed citations
3.
Zhang, Xinhai, Saied Mirshahidi, & Chien-Shing Chen. (2018). Decontamination of Biobank Facilities. Methods in molecular biology. 1897. 227–241. 3 indexed citations
4.
Cao, Huynh, Yi Xu, Rosalia de Necochea-Campion, et al.. (2017). Application of vitamin D and vitamin D analogs in acute myelogenous leukemia. Experimental Hematology. 50. 1–12. 28 indexed citations
5.
Necochea-Campion, Rosalia de, Carlos J. Díaz Osterman, Heng-Wei Hsu, et al.. (2015). AML sensitivity to YM155 is modulated through AKT and Mcl-1. Cancer Letters. 366(1). 44–51. 22 indexed citations
6.
Berenson, James R., Ori Yellin, Chien-Shing Chen, et al.. (2014). A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma. Supportive Care in Cancer. 23(6). 1503–1512. 27 indexed citations
7.
Hsu, Heng-Wei, Rosalia de Necochea-Campion, Vonetta M. Williams, et al.. (2014). Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells. Oral Oncology. 50(7). 662–669. 8 indexed citations
8.
Nin, Dawn Sijin, Azhar Ali, Kōichi Okumura, et al.. (2013). Akt-Induced Phosphorylation of N-CoR at Serine 1450 Contributes to Its Misfolded Conformational Dependent Loss (MCDL) in Acute Myeloid Leukemia of the M5 Subtype. PLoS ONE. 8(8). e70891–e70891. 4 indexed citations
9.
Hsu, Heng-Wei, Nathan R. Wall, Chung-Tsen Hsueh, et al.. (2013). Combination antiangiogenic therapy and radiation in head and neck cancers. Oral Oncology. 50(1). 19–26. 89 indexed citations
10.
Ichim, Thomas E., Boris Minev, Todd A. Braciak, et al.. (2011). Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?. Journal of Translational Medicine. 9(1). 25–25. 22 indexed citations
11.
Necochea-Campion, Rosalia de, Anahit Ghochikyan, Steven F. Josephs, et al.. (2011). Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome. Journal of Translational Medicine. 9(1). 213–213. 25 indexed citations
12.
Xu, Shuoyu, Wanxin Sun, Jianbiao Zhou, et al.. (2010). Pulse-modulated second harmonic imaging microscope quantitatively demonstrates marked increase of collagen in tumor after chemotherapy. Journal of Biomedical Optics. 15(5). 56016–56016. 8 indexed citations
13.
Chen, Chien-Shing, et al.. (2010). Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature. Journal of Hematology & Oncology. 3(1). 12–12. 52 indexed citations
14.
Zhou, Jianbiao, Boon-Cher Goh, Daniel H. Albert, & Chien-Shing Chen. (2009). ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside. Journal of Hematology & Oncology. 2(1). 33–33. 52 indexed citations
15.
Jasinghe, Viraj J., Zhigang Xie, Jianbiao Zhou, et al.. (2008). ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft. Journal of Hepatology. 49(6). 985–997. 31 indexed citations
16.
Xie, Zhigang, Peter Choong, Lai-Fong Poon, et al.. (2008). Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion. Cancer Chemotherapy and Pharmacology. 62(6). 949–957. 45 indexed citations
17.
Zhou, Jianbiao, Viraj J. Jasinghe, Chonglei Bi, et al.. (2008). In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor. Leukemia Research. 32(7). 1091–1100. 19 indexed citations
18.
Koh, Liang‐Piu, Chien-Shing Chen, Bee‐Choo Tai, et al.. (2007). Impact of Postgrafting Immunosuppressive Regimens on Nonrelapse Mortality and Survival after Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant Using the Fludarabine and Low-Dose Total-Body Irradiation 200-cGy. Biology of Blood and Marrow Transplantation. 13(7). 790–805. 10 indexed citations
19.
Shen, Jing, et al.. (2006). Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signaling. Experimental Hematology. 35(1). 75.e1–75.e11. 31 indexed citations
20.
Zhang, Daohai, et al.. (2006). Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study. Leukemia Research. 31(1). 75–82. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Ellinghaus Breakdown of academic impact, for papers by Lita A. Freeman Breakdown of academic impact, for papers by Andrew G. Hall Breakdown of academic impact, for papers by David M. Smalley Breakdown of academic impact, for papers by Zunyan Dai Breakdown of academic impact, for papers by Allan S. Pollock Breakdown of academic impact, for papers by Claudia Friesen Breakdown of academic impact, for papers by Lakshmi Puttagunta Breakdown of academic impact, for papers by Françoise Degoul Breakdown of academic impact, for papers by Ting Zhao
Rankless by CCL
2026